Exogenous surface-active phospholipid protects Necturus gastric mucosa against luminal acid and barrier-breaking agents
- PMID: 1983849
- DOI: 10.1016/0016-5085(91)90580-e
Exogenous surface-active phospholipid protects Necturus gastric mucosa against luminal acid and barrier-breaking agents
Abstract
The nature of the protective action of exogenous surface-active phospholipid on gastric mucosa was studied in isolated Necturus antral mucosa by measuring intracellular pH and intraepithelial potentials and resistances with a microelectrode technique. Exposure of the antral mucosa to luminal pH 2 acidified intracellular pH in surface epithelial cells by 0.6-0.3 pH units. A 20-minute pretreatment with exogenous (pulmonary) surfactanlike phospholipid completely abolished this effect. Obviously, phospholipid protected the mucosa against intracellular acidosis by decreasing the apical cell membrane conductance to H+ (and other ions), because it increased apical cell membrane resistance by +108% and total transcellular resistance by +86% but had no significant effects on paracellular or total transepithelial resistances. In mucosas exposed to three barrier-breaking agents, 10 mmol/L acetylsalicylic acid, 20% (vol/vol) ethanol, and 10 mmol/L taurocholate, at acid luminal perfusate (pH 2.0-2.5), a profound intracellular acidification of 0.9-1.3 pH units/15 min occurred. Pretreatment of the tissue with phospholipid significantly opposed intracellular acidification, but the modulatory influences on the changes in intraepithelial potentials or resistances were less conspicuous and mostly insignificant.
Similar articles
-
Effect of barrier-breaking agents on intracellular pH and epithelial membrane resistances: studies in isolated Necturus antral mucosa exposed to luminal acid.Gastroenterology. 1989 Jun;96(6):1410-8. doi: 10.1016/0016-5085(89)90506-4. Gastroenterology. 1989. PMID: 2714572
-
Topical prostaglandin E2 protects isolated gastric mucosa against acidified taurocholate-, but not ethanol- or aspirin-induced injury.Dig Dis Sci. 2000 Jan;45(1):99-104. doi: 10.1023/a:1005465528158. Dig Dis Sci. 2000. PMID: 10695620
-
Milk and egg phospholipids act as protective surfactants against luminal acid in Necturus gastric mucosa.Aliment Pharmacol Ther. 1995 Dec;9(6):685-91. doi: 10.1111/j.1365-2036.1995.tb00439.x. Aliment Pharmacol Ther. 1995. PMID: 8824657
-
Gastric mucosal acid-base balance.J Intern Med Suppl. 1990;732:63-8. doi: 10.1111/j.1365-2796.1990.tb01474.x. J Intern Med Suppl. 1990. PMID: 2200417 Review.
-
Defense mechanisms of the gastric mucosa.Scand J Gastroenterol Suppl. 1981;67:201-4. Scand J Gastroenterol Suppl. 1981. PMID: 7017894 Review.
Cited by
-
Phospholipid composition of human gastric mucosa: a study of endoscopic biopsy specimens.Gut. 1993 Apr;34(4):456-60. doi: 10.1136/gut.34.4.456. Gut. 1993. PMID: 8491389 Free PMC article.
-
Phospholipids and lipid-based formulations in oral drug delivery.Pharm Res. 2010 Aug;27(8):1469-86. doi: 10.1007/s11095-010-0130-x. Epub 2010 Apr 22. Pharm Res. 2010. PMID: 20411409 Review.
-
Gastric mucosal barrier: barrier to hydrogen ions imparted by gastric surfactant in vitro.Gut. 1992 Aug;33(8):1039-41. doi: 10.1136/gut.33.8.1039. Gut. 1992. PMID: 1398228 Free PMC article.
-
Gastric mucosal barrier: evidence for Helicobacter pylori ingesting gastric surfactant and deriving protection from it.Gut. 1993 May;34(5):588-93. doi: 10.1136/gut.34.5.588. Gut. 1993. PMID: 8504956 Free PMC article.
-
Bromophenacyl bromide, a phospholipase A2 inhibitor attenuates chemically induced gastroduodenal ulcers in rats.World J Gastroenterol. 2006 Sep 28;12(36):5798-804. doi: 10.3748/wjg.v12.i36.5798. World J Gastroenterol. 2006. PMID: 17007045 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources